Abstract
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have